---
title: "Avio Smart Market Stack Limited (ASMS) — Share Price, Financials & Analysis"
symbol: "ASMS"
company: "Avio Smart Market Stack Limited"
canonical: "https://tapetide.com/stocks/ASMS"
isin: "INE855F01042"
nse_symbol: "ASMS"
bse_code: "532694"
sector: "Information Technology"
industry: "IT Enabled Services"
market_cap_cr: 202.85
generated_at: "2026-09-13T19:48:49.440Z"
---

# Avio Smart Market Stack Limited (ASMS)

Canonical page: https://tapetide.com/stocks/ASMS

## Company

- **NSE Symbol:** ASMS
- **BSE Code:** 532694
- **ISIN:** INE855F01042
- **Sector:** Information Technology
- **Industry:** IT Enabled Services
- **Macro Sector:** Information Technology
- **Stock Type:** EQUITY
- **Listed Since:** 2023-02-09
- **CEO:** Mr. Nandaluru Vidhya Sagar Reddy
- **Employees:** 130
- **Face Value:** ₹1
- **F&O Eligible:** No
- **Website:** bartronics.com

## About

Incorporated in 1990, Bartronics India Ltd provides Automatic Identification & Data Capture (AIDC) solutions[1]

## Latest Price

- **Price:** ₹6.88
- **Change:** -0.03 (-0.43%)
- **Open:** ₹6.89
- **Day High:** ₹6.98
- **Day Low:** ₹6.66
- **Previous Close:** ₹6.91
- **Volume:** 141116
- **As Of:** 2026-09-11T10:01:38+00:00

## Key Fundamentals

Observed at 2026-09-11T04:33:52.430206Z.

- **Market Cap:** ₹202.85 Cr
- **Classification:** Microcap
- **P/E (reported):** 32.9
- **P/E (TTM):** 29.91
- **EPS (TTM):** ₹0.23
- **Book Value:** ₹1.12
- **Price to Book:** 6.15
- **Dividend Yield:** 0%
- **ROE:** 78.07%
- **ROCE:** 86.72%
- **Debt to Equity:** 0.26
- **Revenue (yearly):** ₹103.96 Cr
- **Net Income:** ₹5.94 Cr
- **EBITDA:** ₹4.79 Cr
- **52-Week High:** ₹17.2
- **52-Week Low:** ₹6.66
- **RSI (14):** 42.69

## Tapetide Score

- **Score:** 35 / 100
- **Score date:** 2026-09-04
- **Archetype:** Expensive and Under Pressure
- **What it means:** The multiple is demanding and the trend has turned against it, without the financial strength that would justify paying up. What matters is whether the de-rating stops at the multiple or starts showing up in the numbers.
- **Pillar profile:** Quality: Average · Valuation: Expensive · Momentum: Falling
- **Percentile:** 6 (of 4473 scored stocks)
- **Confidence:** 98%
- **Data coverage:** 95%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 51.96 | 9% |
| growth | 98.9 | 9% |
| momentum | 32.56 | 12% |
| ownership | 26.85 | 24% |
| quality | 51.53 | 22% |
| valuation | 27.3 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Strengths

- Company is expected to give good quarter

### Weaknesses

- Stock is trading at 6.13 times its book value
- Though the company is reporting repeated profits, it is not paying out dividend
- Promoter holding has decreased over last quarter: -1.68%
- Company has a low return on equity of 8.50% over last 3 years.
- Contingent liabilities of Rs.115 Cr.
- Debtor days have increased from 38.8 to 90.7 days.

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | -202.26% | -114.82% | -144.1% |
| ebitda margin growth | -62.96% | -4.19% | -47.95% | -68.59% |
| net income growth | -57.14% | -98.56% | 30% | 16% |
| revenue growth | -63.22% | 95.41% | 25% | 11% |
| roce | -65.67% | — | — | 16.24% |
| roe | -55.77% | -203.16% | -16.71% | -287.35% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 12.43 | 11.92 | 12.41 | 13.57 | 8.85 | 8.71 | 8.91 | 8.83 | 12.4 | 48.34 | 34.39 | 11.97 |
| Expenses | 12.82 | 12.1 | 12.56 | 13.34 | 8.91 | 9.08 | 9.01 | 9.65 | 11.7 | 45.75 | 32.06 | 11.26 |
| Operating Profit | -0.39 | -0.18 | -0.15 | 0.23 | -0.06 | -0.37 | -0.1 | -0.82 | 0.7 | 2.59 | 2.33 | 0.71 |
| OPM % | -3.14 | -1.51 | -1.21 | 1.69 | -0.68 | -4.25 | -1.12 | -9.29 | 5.65 | 5.36 | 6.78 | 5.93 |
| Other Income | -0.29 | 0.25 | 0.75 | 0.85 | 0.32 | 0.06 | 1.52 | 0.03 | 0.32 | 0.15 | 0.42 | 0.87 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.07 | 0.27 |
| Depreciation | 0.14 | 0.07 | 0.04 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.06 | 0.05 | 0.08 |
| Profit before tax | -0.82 | 0 | 0.56 | 1.07 | 0.25 | -0.32 | 1.41 | -0.8 | 1.01 | 2.68 | 2.63 | 1.23 |
| Tax % | 20.73 | — | -253.57 | 16.82 | 0 | 0 | 33.33 | -156.25 | 0 | 8.96 | 20.15 | -21.95 |
| Net Profit | -0.99 | -0.06 | 1.98 | 0.89 | 0.25 | -0.33 | 0.93 | 0.45 | 1 | 2.45 | 2.09 | 1.51 |
| EPS in Rs | -0.03 | 0 | 0.07 | 0.03 | 0.01 | -0.01 | 0.03 | 0.01 | 0.03 | 0.08 | 0.07 | 0.05 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 71 | 68 | 66 | 63 | 65 | 53 | 49 | 40 | 104 | 107 |
| Expenses | 58 | 84 | 59 | 57 | 60 | 51 | 49 | 40 | 99 | 101 |
| Operating Profit | 13 | -16 | 7 | 6 | 6 | 2 | 0 | 0 | 5 | 6 |
| OPM % | 18 | -23 | 11 | 9 | 9 | 3.7 | -0.1 | -0.7 | 4.6 | 6 |
| Other Income | 2 | 0 | 3 | 0 | 0 | 158 | 1 | 3 | 1 | 2 |
| Interest | 52 | 52 | 52 | 52 | 52 | 26 | 0 | 0 | 0 | 0 |
| Depreciation | 6 | 5 | 5 | 4 | 4 | 4 | 0 | 0 | 0 | 0 |
| Profit before tax | -43 | -74 | -47 | -50 | -51 | 130 | 0 | 2 | 5 | 8 |
| Tax % | -1 | -10 | 9 | -2 | -1 | 15 | -500 | 27 | -9 | — |
| Net Profit | -43 | -66 | -51 | -49 | -50 | 110 | 1 | 2 | 6 | 7 |
| EPS in Rs | -12.65 | -19.37 | -15.06 | -14.46 | -14.77 | 3.62 | 0.05 | 0.06 | 0.2 | 0.23 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 34 | 34 | 34 | 34 | 34 | 34 | 30 | 30 | 30 | 30 |
| Reserves | 57 | 15 | -27 | -51 | -108 | -147 | -5 | -4 | -2 | 4 |
| Borrowings | 789 | 747 | 797 | 1047 | 1092 | 1156 | 0 | 0 | 0 | 9 |
| Other Liabilities | 585 | 417 | 448 | 244 | 244 | 245 | 2 | 3 | 4 | 25 |
| Total Liabilities | 1465 | 1213 | 1252 | 1274 | 1261 | 1289 | 28 | 30 | 33 | 68 |
| Fixed Assets | 50 | 45 | 39 | 32 | 28 | 24 | 4 | 2 | 0 | 2 |
| CWIP | 14 | 14 | 14 | 12 | 12 | 12 | 0 | 0 | 0 | 0 |
| Investments | 302 | 302 | 306 | 302 | 302 | 302 | 0 | 0 | 5 | 14 |
| Other Assets | 1100 | 852 | 893 | 928 | 919 | 951 | 24 | 28 | 27 | 53 |
| Total Assets | 1465 | 1213 | 1252 | 1274 | 1261 | 1289 | 28 | 30 | 33 | 68 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 4 | 64 | 31 | 61 | 2 | 4 | -9 | 0 | -2 | 1 |
| Cash from Investing Activity | 1 | 0 | 20 | 11 | 0 | 0 | 1 | 1 | -1 | -10 |
| Cash from Financing Activity | -3 | -64 | -52 | -69 | 0 | 0 | -2 | 0 | 0 | 8 |
| Net Cash Flow | 1 | 0 | 0 | 3 | 2 | 4 | -11 | 0 | -3 | 0 |
| Free Cash Flow | 3 | 63 | 31 | 65 | 2 | 4 | -9 | -1 | 2 | 0 |
| CFO/OP | 35 | 494 | -195 | 861 | 35 | 70 | -472 | -4775 | 669 | 29 |

### Ratios

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 4451 | 3248 | 3533 | 3822 | 3932 | 3907 | 16 | 3 | 22 | 91 |
| Inventory Days | 96 | 173 | 81 | 124 | — | 389 | — | — | — | 0 |
| Days Payable | 4922 | 2601 | 1778 | 1872 | — | 4518 | — | — | — | 137 |
| Cash Conversion Cycle | -375 | 820 | 1836 | 2073 | 3932 | -223 | 16 | 3 | 22 | -46 |
| Working Capital Days | -2220 | -2458 | -2815 | -2963 | -3446 | -3526 | 15 | -7 | -7 | 2 |
| ROCE % | 0 | 1 | -3 | 1 | 0 | 0 | 0 | 4 | 1 | 16 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 90% | 90% | 90% | 89.75% | 85.57% | 81.29% | 75% | 75% | 69.37% | 69.37% | 67.5% | 65.82% |
| FIIs | 0% | 0% | 0% | 0% | 0.01% | 3.19% | 3.97% | 1.35% | 1.67% | 1.68% | 1.67% | 1.49% |
| DIIs | 0.22% | 0.22% | 0.22% | 0.22% | 0.22% | 0.22% | 0.22% | 0.22% | 0.22% | 0.22% | 0.22% | 0.22% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 8.6% | 8.42% | 8.41% | 8.46% | 12.41% | 13.34% | 16.32% | 19.3% | 19.78% | 19.72% | 24.66% | 26.32% |
| Others | 1.18% | 1.36% | 1.37% | 1.57% | 1.8% | 1.96% | 4.49% | 4.13% | 8.96% | 9.02% | 5.96% | 6.14% |
| No. of Shareholders | 35948 | 35688 | 38594 | 39275 | 48054 | 50472 | 59477 | 60221 | 61747 | 60788 | 72319 | 71131 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Sell
- **Buy / Neutral / Sell:** 1 / 6 / 12

### Moving Averages — summary: **Strong Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 7.01 | Sell |
| EMA (10) | 6.98 | Sell |
| SMA (20) | 7.01 | Sell |
| EMA (20) | 7.02 | Sell |
| SMA (50) | 7.08 | Sell |
| EMA (50) | 7.14 | Sell |
| SMA (100) | 7.33 | Sell |
| EMA (100) | 7.62 | Sell |
| SMA (200) | 8.97 | Sell |
| EMA (200) | 8.93 | Sell |

### Oscillators — summary: **Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 41.42 | Neutral |
| MACD (12,26,9) | -0.05 | Sell |
| Stochastic (14,3,3) | 35.19 | Neutral |
| ADX (14) | 12.4 | Neutral |
| Williams %R (14) | -69.44 | Neutral |
| ATR (14) | 0.27 | High Volatility |
| ROC (12) | -0.86 | Sell |
| Stoch RSI (14) | 6.97 | Buy |
| UO (7,14,28) | 41.27 | Neutral |

## Filings & Documents

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-09-05 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0bb23602-0abb-4367-9823-fb4bc14badb8.pdf) |
| 2026-09-04 | [Notice Convening The 34Th Annual General Meeting (AGM) Of The Company](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f3e4d18e-70f5-4972-820e-c111a2afa75a.pdf) |
| 2026-09-04 | [Notice Convening The 34Th Annual General Meeting (AGM) Of The Company](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a33f3994-c66e-4a4c-be74-826d568ae1d8.pdf) |
| 2026-09-04 | [Corporate Action- Fix Book Closure For 34Th Annual General Meeting.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4146946a-b3d1-4395-bb6e-5cd498587a52.pdf) |
| 2026-09-04 | [Reg. 34 (1) Annual Report.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=84ed1ad6-00e7-443e-b962-12202207830d.pdf) |
| 2026-09-04 | [Reg. 34 (1) Annual Report.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=18b66a51-32df-4b0d-8866-ca27b370e237.pdf) |
| 2026-09-03 | [Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Of The Company Held On Thursday September 03 2026 Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7037389e-9150-4f99-a415-80065529b021.pdf) |
| 2026-08-31 | [Board Meeting Intimation for Raising Funds And Other Business Items.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9cb69a23-5df8-4c3a-87bf-289f95a09d0b.pdf) |
| 2026-08-12 | [Board Meeting Outcome for Outcome Of Board Meeting Held On August 12 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1efff462-1be3-4457-a957-8d5835e1457f.pdf) |
| 2026-08-12 | [Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Incorporation Of A Step-Down Subsidiary Of The Company](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fe861311-17b5-4f36-840b-2d21266ff123.pdf) |

### Investor Presentations

| Date | Document |
| --- | --- |
| 2026-06-12 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6b1f2031-d6c9-415e-80ef-8e05d19f72c4.pdf) |
| 2026-02-04 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=45000160-e321-4694-9a78-cebbd038e73c.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-05-29 | [Result-Financial Result For The Quarter Ended 31St March 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f6e0aadb-91eb-4e90-ab6e-0dc62f7330e0.pdf) |
| 2026-02-02 | [Result-Financial Result For The Quarter Ended December 31 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=986a98b1-2753-48e8-87f3-8c2063d04009.pdf) |
| 2025-11-14 | [Result-Financial Result For The Quarter And Half-Year Ended 30Th September 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b9b9e83f-0f64-4153-9566-0c40a2302a7d.pdf) |
| 2025-08-08 | [Result-Financial Result For The Quarter Ended 30.06.2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cf4f69e8-d4b8-41d5-80b3-d340775f2952.pdf) |
| 2025-02-13 | [Result-Financial Result For Quarter Ended 31St December 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=76e02311-9cff-42bf-b4b7-939806d81ac3.pdf) |
| 2024-11-13 | [Declaration Of Un-Audited Financial Results For The Quarter And Half Year Ended 30.09.2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6f66bec6-b5a5-41d1-af4f-4fe0716d1d4d.pdf) |
| 2024-08-14 | [Un-Audited Financial Results For The Quarter Ended 30, June, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=10e9d558-cf9c-4437-9139-4b9f6635b0de.pdf) |
| 2024-05-27 | [Results March 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a75bf74e-10e0-47ab-bee2-4b7d4a2fb3dc.pdf) |
| 2024-02-13 | [Results](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=35dd5f0b-ad47-4a24-b117-5d544f242246.pdf) |
| 2023-11-14 | [Financial Results](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8a1fae75-57fe-4d67-ab7d-7b384dda592d.pdf) |

### Other Documents

| Date | Document |
| --- | --- |
| 9 Apr - AYOU expands agri-commerce operations to Hyderabad; commercial launch expected in early May 2026. | [Announcement under Regulation 30 (LODR)-Press Release / Media Release 9 Apr - AYOU expands agri-commerce operations to Hyderabad; commercial launch expected in early May 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/7835d8b5-13e6-4089-90de-923254be5dea.pdf) |
| 8 Apr - On 8 April 2026, company made further ₹4 crore investment in Huwel Lifesciences for 1.11% stake. | [Announcement under Regulation 30 (LODR)-Updates on Acquisition 8 Apr - On 8 April 2026, company made further ₹4 crore investment in Huwel Lifesciences for 1.11% stake.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/31d4c886-215c-48a6-b86c-92f22e0ab3bd.pdf) |
| 8 Apr - Company invested ₹1 crore in Shree Naganarasimha Private Limited for 20.48% stake. | [Announcement under Regulation 30 (LODR)-Updates on Acquisition 8 Apr - Company invested ₹1 crore in Shree Naganarasimha Private Limited for 20.48% stake.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/a8af3a3b-4328-4d65-8f55-5b6c837bf6d9.pdf) |
| 6 Mar - 6 Mar 2026: ASMS partners with Huwel to commercialize patented molecular diagnostics nationwide, TB platform approved. | [Announcement under Regulation 30 (LODR)-Press Release / Media Release 6 Mar - 6 Mar 2026: ASMS partners with Huwel to commercialize patented molecular diagnostics nationwide, TB platform approved.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/1c06e4b0-35a1-4f6f-89f3-59ee21273dc8.pdf) |
| 5 Jan - Certificate confirming dematerialization/rematerialization details furnished for quarter ended 31 Dec 2025. | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 5 Jan - Certificate confirming dematerialization/rematerialization details furnished for quarter ended 31 Dec 2025.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/f663b25f-0fd4-427c-b473-b96e6a84c2dd.pdf) |
| 4 Feb - Board meeting on Feb 10, 2026 to approve Q3 (Dec 31, 2025) unaudited standalone financial results. | [Board Meeting Intimation for Unaudited Results For The Quarter Ended 31St December, 2025 4 Feb - Board meeting on Feb 10, 2026 to approve Q3 (Dec 31, 2025) unaudited standalone financial results.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/0abb1a6b-4318-4a81-ae77-5a65f779e5dd.pdf) |
| 30 Mar - 30-Mar-2026: ASMS wins Indian Overseas Bank PO for 3-year CBC services, scaling to ~500 rural touchpoints. | [Announcement under Regulation 30 (LODR)-Press Release / Media Release 30 Mar - 30-Mar-2026: ASMS wins Indian Overseas Bank PO for 3-year CBC services, scaling to ~500 rural touchpoints.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/c59910ab-366d-497a-aabd-8a510a82422f.pdf) |
| 29 Apr - ASMS and Huwel announce upcoming launch of Cubo RT-PCR diagnostics platform on April 29, 2026. | [Announcement under Regulation 30 (LODR)-Press Release / Media Release 29 Apr - ASMS and Huwel announce upcoming launch of Cubo RT-PCR diagnostics platform on April 29, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/887808ee-897d-4bd1-9c00-9c3784ddce6a.pdf) |
| 29 Apr - ASMS and Huwel announce upcoming launch of Cubo RT-PCR diagnostics platform on April 29, 2026. | [Announcement under Regulation 30 (LODR)-Press Release / Media Release 29 Apr - ASMS and Huwel announce upcoming launch of Cubo RT-PCR diagnostics platform on April 29, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/887808ee-897d-4bd1-9c00-9c3784ddce6a.pdf) |
| 27 Apr - ASMS and Huwel onboard Singapore partner to expand Quantiplus across Southeast Asia. | [Announcement under Regulation 30 (LODR)-Press Release / Media Release 27 Apr - ASMS and Huwel onboard Singapore partner to expand Quantiplus across Southeast Asia.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/d35daa6b-bd96-4bfc-b0dd-6f9eb5cefe7c.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Feb 2026 | [Concall - Feb 2026](https://www.bseindia.com/xml-data/corpfiling/AttachHis/45000160-e321-4694-9a78-cebbd038e73c.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from nse | [Annual Report 2013 from nse](https://archives.nseindia.com/annual_reports/AR_3084_BARTRONICS_2012_2013_26122013091600.zip) |
| from nse | [Financial Year 2011 from nse](https://archives.nseindia.com/annual_reports/AR_TCIFINANCE_2010_2011_15062012100230.zip) |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/d9107656-ac85-46f2-8c0e-97a625fb7be9.pdf) |
| from bse | [Annual Report 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/c74b3058-9a46-4937-81ae-4a8f4f08622b.pdf) |
| from bse | [Financial Year 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/fd0e72f2-2b1f-468a-93f6-49012a97a25d.pdf) |
| from bse | [Annual Report 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/301f842b-2acb-42ab-b8d4-1400568e2e18.pdf) |
| from bse | [Financial Year 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/94e68140-f24c-4ab6-bdd7-ab1535a8a22f.pdf) |
| from bse | [Annual Report 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/532694/77309532694.pdf) |
| from bse | [Financial Year 2022 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/42d2f461-2c54-42a0-a347-88350a4ed631.pdf) |
| from bse | [Annual Report 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/532694/71065532694.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T19:48:49.440Z.